{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T15:34:07Z","timestamp":1781278447274,"version":"3.54.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s10585-024-10321-2","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T04:08:27Z","timestamp":1735531707000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Establishing patient-derived tumor organoids of bone metastasis from lung adenocarcinoma reveals the transcriptomic changes underlying denosumab treatment"],"prefix":"10.1007","volume":"42","author":[{"given":"Xianglin","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huajian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kewen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yani","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqiang","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mo","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangjun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wending","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,30]]},"reference":[{"issue":"3","key":"10321_CR1","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00402-020-03417-3","volume":"141","author":"MH Younis","year":"2021","unstructured":"Younis MH, Fuentes-Rivera L, Summers S et al (2021) Survival in patients with carcinomas presenting with bone metastasis at diagnosis: a SEER population-based cohort study. Arch Orthop Trauma Surg 141(3):367\u2013373","journal-title":"Arch Orthop Trauma Surg"},{"issue":"1","key":"10321_CR2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s13167-022-00270-9","volume":"13","author":"X Hu","year":"2022","unstructured":"Hu X, Huang W, Sun Z et al (2022) Predictive factors, preventive implications, and personalized surgical strategies for bone metastasis from lung cancer: population-based approach with a comprehensive cancer center-based study. EPMA J 13(1):57\u201375","journal-title":"EPMA J"},{"issue":"1","key":"10321_CR3","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1185\/03007995.2015.1105795","volume":"32","author":"G G\u00fcl","year":"2016","unstructured":"G\u00fcl G, Sendur MA, Aksoy S, Sever AR, Altundag K (2016) A comprehensive review of denosumab for bone metastasis in patients with solid tumors. Curr Med Res Opin 32(1):133\u2013145","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"10321_CR4","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1007\/s00586-021-07032-7","volume":"31","author":"S Cao","year":"2022","unstructured":"Cao S, Gao X, Zhang Y et al (2022) A comparison of two different surgical procedures in the treatment of isolated spinal metastasis patients with metastatic spinal cord compression: a case-control study. Eur Spine J 31(6):1583\u20131589","journal-title":"Eur Spine J"},{"issue":"12","key":"10321_CR5","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1158\/0008-5472.CAN-20-4026","volume":"81","author":"M Gr\u00f6nholm","year":"2021","unstructured":"Gr\u00f6nholm M, Feodoroff M, Antignani G et al (2021) Patient-derived organoids for precision cancer immunotherapy. Cancer Res 81(12):3149\u20133155","journal-title":"Cancer Res"},{"key":"10321_CR6","doi-asserted-by":"publisher","first-page":"e101654","DOI":"10.15252\/embj.2019101654","volume":"38","author":"M Bleijs","year":"2019","unstructured":"Bleijs M, Wetering M, Clevers H et al (2019) Xenograft and organoid model systems in cancer research. EMBO J 38:e101654","journal-title":"EMBO J"},{"issue":"4","key":"10321_CR7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1093\/procel\/pwad038","volume":"15","author":"Y Mao","year":"2024","unstructured":"Mao Y, Wang W, Yang J et al (2024) Drug repurposing screening and mechanism analysis based on human colorectal cancer organoids. Protein Cell 15(4):285\u2013304","journal-title":"Protein Cell"},{"issue":"1\u20132","key":"10321_CR8","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.cell.2017.11.010","volume":"172","author":"N Sachs","year":"2018","unstructured":"Sachs N, de Ligt J, Kopper O et al (2018) A living biobank of breast cancer organoids captures disease heterogeneity. Cell 172(1\u20132):373-386e10","journal-title":"Cell"},{"issue":"2","key":"10321_CR9","doi-asserted-by":"publisher","first-page":"100911","DOI":"10.1016\/j.xcrm.2022.100911","volume":"4","author":"HM Wang","year":"2023","unstructured":"Wang HM, Zhang CY, Peng KC et al (2023) Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: a real-world study. Cell Rep Med 4(2):100911","journal-title":"Cell Rep Med"},{"issue":"6","key":"10321_CR10","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.stem.2018.09.016","volume":"23","author":"HHN Yan","year":"2018","unstructured":"Yan HHN, Siu HC, Law S et al (2018) A comprehensive human gastric cancer organoid biobank captures tumor subtype heterogeneity and enables therapeutic screening. Cell Stem Cell 23(6):882-897e11","journal-title":"Cell Stem Cell"},{"issue":"5","key":"10321_CR11","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.cell.2020.10.023","volume":"183","author":"K Kawasaki","year":"2020","unstructured":"Kawasaki K, Toshimitsu K, Matano M et al (2020) An organoid biobank of neuroendocrine neoplasms enables genotype-phenotype mapping. Cell 183(5):1420-1435e21","journal-title":"Cell"},{"issue":"10","key":"10321_CR12","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.1038\/s41596-020-0379-4","volume":"15","author":"E Driehuis","year":"2020","unstructured":"Driehuis E, Kretzschmar K, Clevers H (2020) Establishment of patient-derived cancer organoids for drug-screening applications. Nat Protoc 15(10):3380\u20133409","journal-title":"Nat Protoc"},{"issue":"5","key":"10321_CR13","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1158\/1078-0432.CCR-19-1376","volume":"26","author":"R Shi","year":"2020","unstructured":"Shi R, Radulovich N, Ng C et al (2020) Organoid cultures as preclinical models of non-small cell lung cancer. Clin Cancer Res 26(5):1162\u20131174","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10321_CR14","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1038\/s41467-021-22676-1","volume":"12","author":"Y Hu","year":"2021","unstructured":"Hu Y, Sui X, Song F et al (2021) Lung cancer organoids analyzed on microwell arrays predict drug responses of patients within a week. Nat Commun 12(1):2581","journal-title":"Nat Commun"},{"key":"10321_CR15","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s13402-020-00512-w","volume":"43","author":"X Ma","year":"2020","unstructured":"Ma X, Yu J (2020) Role of the bone microenvironment in bone metastasis of malignant tumors - therapeutic implications. Cell Oncol 43:751\u2013761","journal-title":"Cell Oncol"},{"issue":"7","key":"10321_CR16","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1002\/mc.23541","volume":"62","author":"XR Yang","year":"2023","unstructured":"Yang XR, Pi C, Zhang YC et al (2023) Heterogeneity in the immune microenvironment of bone metastasis in driver-positive non-small cell lung cancer. Mol Carcinog 62(7):1001\u20131008","journal-title":"Mol Carcinog"},{"issue":"7979","key":"10321_CR17","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/s41586-023-06519-1","volume":"621","author":"J Sun","year":"2023","unstructured":"Sun J, Hu L, Bok S et al (2023) A vertebral skeletal stem cell lineage driving metastasis. Nature 621(7979):602\u2013609","journal-title":"Nature"},{"issue":"8","key":"10321_CR18","doi-asserted-by":"publisher","first-page":"8818","DOI":"10.21037\/apm-21-1595","volume":"10","author":"X Huang","year":"2021","unstructured":"Huang X, Shi X, Huang D et al (2021) Mutational characteristics of bone metastasis of lung cancer. Ann Palliat Med 10(8):8818\u20138826","journal-title":"Ann Palliat Med"},{"issue":"8","key":"10321_CR19","doi-asserted-by":"publisher","first-page":"e162054","DOI":"10.1172\/JCI162054","volume":"133","author":"YJ Jeong","year":"2023","unstructured":"Jeong YJ, Knutsdottir H, Shojaeian F et al (2023) Morphology-guided transcriptomic analysis of human pancreatic cancer organoids reveals microenvironmental signals that enhance invasion. J Clin Invest 133(8):e162054","journal-title":"J Clin Invest"},{"issue":"9","key":"10321_CR20","first-page":"967","volume":"57","author":"TH Chiu","year":"2021","unstructured":"Chiu TH, Lin CY, Hsieh MH et al (2021) Prognostic factors in lung adenocarcinoma with bone metastasis treated with EGFR-TKIs. Med (Kaunas) 57(9):967","journal-title":"Med (Kaunas)"},{"key":"10321_CR21","doi-asserted-by":"publisher","first-page":"908436","DOI":"10.3389\/fimmu.2022.908436","volume":"13","author":"HS Li","year":"2022","unstructured":"Li HS, Lei SY, Li JL et al (2022) Efficacy and safety of concomitant immunotherapy and denosumab in patients with advanced non-small cell lung cancer carrying bone metastases: a retrospective chart review. Front Immunol 13:908436","journal-title":"Front Immunol"},{"key":"10321_CR22","doi-asserted-by":"publisher","first-page":"697298","DOI":"10.3389\/fimmu.2021.697298","volume":"12","author":"A Bongiovanni","year":"2021","unstructured":"Bongiovanni A, Foca F, Menis J et al (2021) Immune checkpoint inhibitors with or without bone-targeted therapy in NSCLC patients with bone metastases and prognostic significance of neutrophil-to-lymphocyte ratio. Front Immunol 12:697298","journal-title":"Front Immunol"},{"key":"10321_CR23","doi-asserted-by":"publisher","first-page":"6309219","DOI":"10.1155\/2016\/6309219","volume":"2016","author":"ML Diller","year":"2016","unstructured":"Diller ML, Kudchadkar RR, Delman KA et al (2016) Balancing inflammation: the link between Th17 and regulatory T cells. Mediators Inflamm 2016:6309219","journal-title":"Mediators Inflamm"},{"issue":"5","key":"10321_CR24","doi-asserted-by":"publisher","first-page":"e90772","DOI":"10.1172\/jci.insight.90772","volume":"2","author":"JS Bowers","year":"2017","unstructured":"Bowers JS, Nelson MH, Majchrzak K et al (2017) Th17 cells are refractory to senescence and retain robust antitumor activity after long-term ex vivo expansion. JCI Insight 2(5):e90772","journal-title":"JCI Insight"},{"issue":"1","key":"10321_CR25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1080\/08923973.2019.1566925","volume":"41","author":"S Najafi","year":"2019","unstructured":"Najafi S, Mirshafiey A (2019) The role of T helper 17 and regulatory T cells in tumor microenvironment. Immunopharmacol Immunotoxicol 41(1):16\u201324","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"3","key":"10321_CR26","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1002\/jcb.23009","volume":"112","author":"LM Chen","year":"2011","unstructured":"Chen LM, Kuo CH, Lai TY et al (2011) RANKL increases migration of human lung cancer cells through intercellular adhesion molecule-1 up-regulation. J Cell Biochem 112(3):933\u2013941","journal-title":"J Cell Biochem"},{"key":"10321_CR27","doi-asserted-by":"publisher","first-page":"102836","DOI":"10.1016\/j.sbi.2024.102836","volume":"87","author":"X Zhang","year":"2024","unstructured":"Zhang X, Blumenthal RM, Cheng X (2024) Updated understanding of the protein-DNA recognition code used by C2H2 zinc finger proteins. Curr Opin Struct Biol 87:102836","journal-title":"Curr Opin Struct Biol"},{"key":"10321_CR28","doi-asserted-by":"publisher","first-page":"1129889","DOI":"10.3389\/fphys.2023.1129889","volume":"14","author":"Q Li","year":"2023","unstructured":"Li Q, Tan G, Wu F (2023) The functions and roles of C2H2 zinc finger proteins in hepatocellular carcinoma. Front Physiol 14:1129889","journal-title":"Front Physiol"},{"issue":"1","key":"10321_CR29","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40364-021-00345-1","volume":"10","author":"X Li","year":"2022","unstructured":"Li X, Han M, Zhang H et al (2022) Structures and biological functions of zinc finger proteins and their roles in hepatocellular carcinoma. Biomark Res 10(1):2","journal-title":"Biomark Res"},{"issue":"10","key":"10321_CR30","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1158\/1541-7786.MCR-17-0114","volume":"15","author":"M Harada","year":"2017","unstructured":"Harada M, Sakai S, Ohhata T et al (2017) Homeobox transcription factor NKX2-1 promotes cyclin D1 transcription in lung adenocarcinomas. Mol Cancer Res 15(10):1388\u20131397","journal-title":"Mol Cancer Res"},{"issue":"8","key":"10321_CR31","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1158\/1078-0432.CCR-07-1523","volume":"14","author":"T Kato","year":"2008","unstructured":"Kato T, Sato N, Takano A et al (2008) Activation of placenta-specific transcription factor distal-less homeobox 5 predicts clinical outcome in primary lung cancer patients. Clin Cancer Res 14(8):2363\u20132370","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10321_CR32","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1002\/mc.22439","volume":"55","author":"SL Yu","year":"2016","unstructured":"Yu SL, Lee DC, Sohn HA et al (2016) Homeobox A9 directly targeted by miR-196b regulates aggressiveness through nuclear factor-kappa B activity in non-small cell lung cancer cells. Mol Carcinog 55(12):1915\u20131926","journal-title":"Mol Carcinog"},{"issue":"1","key":"10321_CR33","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12957-023-02969-z","volume":"21","author":"J He","year":"2023","unstructured":"He J, Jiang M, Liu J et al (2023) Homeobox D9 drives the malignant phenotypes and enhances the programmed death ligand-1 expression in non-small cell lung cancer cells via binding to angiopoietin-2 promoter. World J Surg Oncol 21(1):93","journal-title":"World J Surg Oncol"},{"issue":"1","key":"10321_CR34","doi-asserted-by":"publisher","first-page":"413","DOI":"10.21037\/tcr-23-2344","volume":"13","author":"S Jiang","year":"2024","unstructured":"Jiang S, Wang T, Han Y et al (2024) Downregulation of homeobox B8 in attenuating non-small cell lung cancer cell migration and invasion though the epithelial-mesenchymal transition pathway. Transl Cancer Res 13(1):413\u2013422","journal-title":"Transl Cancer Res"},{"key":"10321_CR35","doi-asserted-by":"publisher","first-page":"105557","DOI":"10.1016\/j.biocel.2019.06.005","volume":"114","author":"J Zhang","year":"2019","unstructured":"Zhang J, Yang M, Li D et al (2019) Homeobox C8 is a transcriptional repressor of E-cadherin gene expression in non-small cell lung cancer. Int J Biochem Cell Biol 114:105557","journal-title":"Int J Biochem Cell Biol"},{"issue":"3","key":"10321_CR36","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3233\/CBM-200540","volume":"31","author":"Y Wang","year":"2021","unstructured":"Wang Y, He B, Dong Y et al (2021) Homeobox-A13 acts as a functional prognostic and diagnostic biomarker via regulating P53 and wnt signaling pathways in lung cancer. Cancer Biomark 31(3):239\u2013254","journal-title":"Cancer Biomark"}],"container-title":["Clinical & Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-024-10321-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10585-024-10321-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-024-10321-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T08:01:50Z","timestamp":1738742510000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10585-024-10321-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,30]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10321"],"URL":"https:\/\/doi.org\/10.1007\/s10585-024-10321-2","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,30]]},"assertion":[{"value":"13 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"\u00a0Institutional approval was obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Patients signed informed consent for specimen collection before surgery","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"8"}}